Zacks Investment Research on MSN
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
Insights from analysts' 12-month price targets are revealed, presenting an average target of $5.62, a high estimate of $7.00, and a low estimate of $3.50. This current average has increased by 60.57% ...
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is one of the best small cap stocks with the highest upside. H.C. Wainwright ...
Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...
Sionna Therapeutics said it started a Phase 2a proof-of-concept trial evaluating the results of SION-719, a nucleotide binding domain (NBD1) stabilizer, when added to Trikafta, which is the current ...
Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc.
Deep-pocketed investors have adopted a bullish approach towards Nektar Therapeutics (NASDAQ:NKTR), and it's something market players shouldn't ignore. Our tracking of public options records at ...
Iambic Therapeutics said on Monday early-stage data of its experimental drug showed anti-tumor activity in heavily pretreated cancer patients with mutations in the HER2 gene.
Since then, supply has returned thanks to Lilly's investments in manufacturing and a move to also offer Zepbound, previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results